| 1 | Study of Flavonoids presente in Pomelo (Citrus máxima) by DS… (10.22456/2527-2616.74097) | ORCID | 39.21 | 36 |
| 2 | UV Spectrophotometric method for quantitative determination… (10.22456/2527-2616.79221) | ORCID | 35.37 | 25 |
| 3 | Sitagliptin phosphate: isolation and identification of two d… (10.22456/2527-2616.133259) | References ORCID | 34.95 | 4 |
| 4 | Phytochemical analysis using GC-FID, FPLC fingerprinting, an… (10.22456/2527-2616.110344) | ORCID | 34.51 | 23 |
| 5 | Green analytical method for quantification of Secnidazole in… (10.22456/2527-2616.89411) | ORCID | 32.53 | 19 |
| 6 | Cannabis sativa: A systematic review of plant analysis (10.22456/2527-2616.73676) | ORCID | 31.97 | 18 |
| 7 | Quantitative analysis of pharmaceutical products by spectrop… (10.22456/2527-2616.127631) | References ORCID | 30.10 | 3 |
| 8 | Stability-indicating RP-HPLC method applied to the quantific… (10.22456/2527-2616.128122) | References ORCID | 30.10 | 3 |
| 9 | Eco-Friendly green liquid chromatographic for determination… (10.22456/2527-2616.89412) | ORCID | 30.10 | 15 |
| 10 | New, green and miniaturized analytical method for determinat… (10.22456/2527-2616.91086) | ORCID | 29.40 | 14 |
| 11 | Quantification of Atropine in Leaves of Atropa belladonna: D… (10.22456/2527-2616.74150) | ORCID | 28.65 | 13 |
| 12 | A new and ecological miniaturized method by spectrophotometr… (10.22456/2527-2616.112226) | ORCID | 26.03 | 10 |
| 13 | Development and validation of an ecological, new and rapid s… (10.22456/2527-2616.73755) | ORCID | 26.03 | 10 |
| 14 | Eco-friendly and miniaturized analytical method for quantifi… (10.22456/2527-2616.98376) | ORCID | 26.03 | 10 |
| 15 | Development and validation of UV Spectrophotometric method f… (10.22456/2527-2616.125170) | ORCID | 23.86 | 8 |
| 16 | Simultaneous analysis of dapagliflozin and its three related… (10.22456/2527-2616.128661) | References ORCID | 23.86 | 2 |
| 17 | An Optimized Box-Behnken Design RP-HPLC Method For The Quant… (10.22456/2527-2616.138200) | References ORCID | 23.86 | 2 |
| 18 | Second-Order Derivative UV Spectrophotometric and RP-HPLC Me… (10.22456/2527-2616.86511) | ORCID | 23.86 | 8 |
| 19 | Lipid core nanocapsules-loaded tacrolimus: Development and e… (10.22456/2527-2616.125229) | ORCID | 22.58 | 7 |
| 20 | UV Spectrophotometric method for quantitative determination… (10.22456/2527-2616.79219) | ORCID | 22.58 | 7 |
| 21 | MDMA electrochemical determination in aqueous media containi… (10.22456/2527-2616.101162) | ORCID | 21.13 | 6 |
| 22 | Validation of a green spectrophotometric method for the dete… (10.22456/2527-2616.108127) | ORCID | 21.13 | 6 |
| 23 | Pharmacopoeial HPLC methodology improvement: A case study of… (10.22456/2527-2616.108512) | ORCID | 21.13 | 6 |
| 24 | Development and validation of a dissolution test for empagli… (10.22456/2527-2616.112077) | ORCID | 21.13 | 6 |
| 25 | Development and Validation of UV Spectrophotometric methods… (10.22456/2527-2616.140749) | References | 21.13 | 6 |
| 26 | Validation of a simple reversed Phase-HPLC method for determ… (10.22456/2527-2616.87929) | ORCID | 21.13 | 6 |
| 27 | Rifampicin: biotransformation study using the fungus Cunning… (10.22456/2527-2616.101989) | ORCID | 19.45 | 5 |
| 28 | Antifungal activity of essential oils from Cinnamomum cassia… (10.22456/2527-2616.104615) | ORCID | 19.45 | 5 |
| 29 | Polymeric nanoparticles loaded naringin and naringenin: effe… (10.22456/2527-2616.108783) | ORCID | 19.45 | 5 |
| 30 | Development of derivative spectrophotometric method for simu… (10.22456/2527-2616.111454) | ORCID | 19.45 | 5 |
| 31 | Analytical methods of phytochemicals from the Cuphea genus -… (10.22456/2527-2616.120618) | ORCID | 19.45 | 5 |
| 32 | Analytical method by liquid chromatography to assay piperine… (10.22456/2527-2616.80366) | ORCID | 19.45 | 5 |
| 33 | Development and validation of a simples and fast method for… (10.22456/2527-2616.84248) | ORCID | 19.45 | 5 |
| 34 | Analysis of vanillin by TLC and HPLC-PDA in herbal material… (10.22456/2527-2616.87008) | ORCID | 19.45 | 5 |
| 35 | Development and validation of a LC-ESI-MS/MS method for simu… (10.22456/2527-2616.97423) | ORCID | 19.45 | 5 |
| 36 | Analysis of seized stanozolol formulations in South Brazil b… (10.22456/2527-2616.108853) | ORCID | 17.47 | 4 |
| 37 | Evaluation of quality and safety parameters of DEET commerci… (10.22456/2527-2616.124882) | ORCID | 17.47 | 4 |
| 38 | Quantification of the components in commercial essential oil… (10.22456/2527-2616.79217) | ORCID | 17.47 | 4 |
| 39 | The effect of pH on the simultaneous determination of Sulfam… (10.22456/2527-2616.79218) | ORCID | 17.47 | 4 |
| 40 | Qualitative Analysis of Hydroxyurea (10.22456/2527-2616.100682) | ORCID | 15.05 | 3 |
| 41 | pH Effect on Stability and Kinetics Degradation of Nitazoxan… (10.22456/2527-2616.101465) | ORCID | 15.05 | 3 |
| 42 | Chlorine determination in medicinal plants by potentiometry… (10.22456/2527-2616.108933) | ORCID | 15.05 | 3 |
| 43 | Ozonized oils: a review of its quality control, stability an… (10.22456/2527-2616.113278) | ORCID | 15.05 | 3 |
| 44 | Bilastine: stability-indicating a method using environmental… (10.22456/2527-2616.120940) | ORCID | 15.05 | 3 |
| 45 | Bioactive composition and TLC profile data on Pax Herbal Mal… (10.22456/2527-2616.125038) | ORCID | 15.05 | 3 |
| 46 | Phytochemical profile, in-vitro antioxidant, anti-diabetic a… (10.22456/2527-2616.132488) | References ORCID | 15.05 | 1 |
| 47 | Rapid and sensitive quantification of efavirenz in rat plasm… (10.22456/2527-2616.137367) | References ORCID | 15.05 | 1 |
| 48 | Investigating the Panax ginseng proteome using an in silico… (10.22456/2527-2616.139143) | References ORCID | 15.05 | 1 |
| 49 | Development and validation of HPLC and GC methods for quanti… (10.22456/2527-2616.139666) | References | 15.05 | 3 |
| 50 | Miniaturized Extraction Techniques in Drug Biotransformation… (10.22456/2527-2616.140446) | References ORCID | 15.05 | 1 |
| 51 | FIRST EDITION (10.22456/2527-2616.75900) | References ORCID | 15.05 | 1 |
| 52 | Characterization of linagliptin using analytical techniques (10.22456/2527-2616.79220) | ORCID | 15.05 | 3 |
| 53 | LC-MS/MS method for the simultaneous estimation of Cefepime… (10.22456/2527-2616.84357) | ORCID | 15.05 | 3 |
| 54 | Stability-indicating LC method for the quantification of Mid… (10.22456/2527-2616.86375) | ORCID | 15.05 | 3 |
| 55 | Development and Validation of UV Spectrophotometry and Liqui… (10.22456/2527-2616.93809) | ORCID | 15.05 | 3 |
| 56 | Evaluation of linagliptin dissolution from tablets using HPL… (10.22456/2527-2616.97847) | ORCID | 15.05 | 3 |
| 57 | Second-derivative spectrophotometry for the analysis of simv… (10.22456/2527-2616.98057) | ORCID | 15.05 | 3 |
| 58 | Stability-Indicating HPLC Method for isoflavones aglycones a… (10.22456/2527-2616.102027) | ORCID | 11.93 | 2 |
| 59 | Development of nanoemulsions containing penciclovir for herp… (10.22456/2527-2616.103121) | ORCID | 11.93 | 2 |
| 60 | Counterfeit medicines: a pilot study for chemical profiling… (10.22456/2527-2616.107986) | ORCID | 11.93 | 2 |
| 61 | Novel ultraviolet absorbers derived from cashew nut shell li… (10.22456/2527-2616.108405) | ORCID | 11.93 | 2 |
| 62 | Post mortem changes: challenges in drug analysis in the diag… (10.22456/2527-2616.111711) | ORCID | 11.93 | 2 |
| 63 | A novel sensitive colorimetric determination of catecholamin… (10.22456/2527-2616.113058) | ORCID | 11.93 | 2 |
| 64 | A complete study of Doxazosin characterization (10.22456/2527-2616.73960) | ORCID | 11.93 | 2 |
| 65 | Determination of Pinaverium Bromide in pharmaceutical dosage… (10.22456/2527-2616.73964) | ORCID | 11.93 | 2 |
| 66 | Feasibility study of antiseptic gel formulations containing… (10.22456/2527-2616.77118) | ORCID | 11.93 | 2 |
| 67 | Validation of a simple method for simultaneous determination… (10.22456/2527-2616.82578) | ORCID | 11.93 | 2 |
| 68 | Microbiological assay for the determination of cefpirome in… (10.22456/2527-2616.84473) | ORCID | 11.93 | 2 |
| 69 | Evaluation of the stability of Vigabatrin in hospitalar exte… (10.22456/2527-2616.94436) | ORCID | 11.93 | 2 |
| 70 | Development and validation of analytical methodology for qua… (10.22456/2527-2616.96926) | ORCID | 11.93 | 2 |
| 71 | Development and validation of a stability-indicating analyti… (10.22456/2527-2616.102740) | ORCID | 7.53 | 1 |
| 72 | Evaluation of Physical-Chemical and Microbiological Stabilit… (10.22456/2527-2616.103473) | ORCID | 7.53 | 1 |
| 73 | Use of Box–Behnken design for optimization of compounded med… (10.22456/2527-2616.113283) | ORCID | 7.53 | 1 |
| 74 | Evaluation of artificial drug incorporation into hair for th… (10.22456/2527-2616.118887) | ORCID | 7.53 | 1 |
| 75 | Ceftaroline fosamil: development a rapid HPLC method indicat… (10.22456/2527-2616.120343) | ORCID | 7.53 | 1 |
| 76 | Development of calcium alginate beads containing paclitaxel-… (10.22456/2527-2616.122299) | ORCID | 7.53 | 1 |
| 77 | Development and validation of a new analytical method based… (10.22456/2527-2616.133273) | References | 7.53 | 1 |
| 78 | Main Compounds and Major Methods in Latent Fingermark Aging… (10.22456/2527-2616.133299) | References | 7.53 | 1 |
| 79 | Green method for quantification of gatifloxacin in eye drops… (10.22456/2527-2616.134965) | References | 7.53 | 1 |
| 80 | Development and Assessment of the Stability of Hospital Deri… (10.22456/2527-2616.137468) | References | 7.53 | 1 |
| 81 | Valproic acid extraction methods in human samples for gas ch… (10.22456/2527-2616.138963) | References | 7.53 | 1 |
| 82 | Chemical composition and antimycotic potential of basil, ros… (10.22456/2527-2616.140970) | References | 7.53 | 1 |
| 83 | Lean and eco-efficient method for evaluating the potency of… (10.22456/2527-2616.143057) | References | 7.53 | 1 |
| 84 | Validated HPLC Methodology for Pregabalin Quantification in… (10.22456/2527-2616.143059) | References | 7.53 | 1 |
| 85 | Multicomponent Spectrophotometric Method for Simultaneous An… (10.22456/2527-2616.74119) | ORCID | 7.53 | 1 |
| 86 | Green analytical method for quantification of Secnidazole in… (10.22456/2527-2616.88545) | ORCID | 7.53 | 1 |
| 87 | Evaluation of the presence of polymorphic forms and influenc… (10.22456/2527-2616.90005) | ORCID | 7.53 | 1 |
| 88 | Bioanalytical method by column-switching with direct injecti… (10.22456/2527-2616.91542) | ORCID | 7.53 | 1 |
| 89 | Determination of Doxorubicin Hydrochloride in Pharmaceutical… (10.22456/2527-2616.91896) | ORCID | 7.53 | 1 |
| 90 | Biotransformation of Metronidazole by Cunninghamella elegans… (10.22456/2527-2616.94032) | ORCID | 7.53 | 1 |
| 91 | Sensitive ultra-fast liquid chromatography method for rosmar… (10.22456/2527-2616.96433) | ORCID | 7.53 | 1 |
| 92 | Quality evaluation of minoxidil topical solutions obtained f… (10.22456/2527-2616.98396) | ORCID | 7.53 | 1 |
| 93 | Editorial Team (10.22456/2527-2616.105399) | References ORCID | 0.00 | 0 |
| 94 | Simple method for simultaneous quantification of two new der… (10.22456/2527-2616.108249) | ORCID | 0.00 | 0 |
| 95 | Editorial Team (10.22456/2527-2616.109989) | References ORCID | 0.00 | 0 |
| 96 | template 3 (10.22456/2527-2616.117256) | Abstract References ORCID | 0.00 | 0 |
| 97 | Lead evaluation in children's lipsticks through atomic absor… (10.22456/2527-2616.117544) | ORCID | 0.00 | 0 |
| 98 | Rapid stability-indicating UHPLC method for determination of… (10.22456/2527-2616.117905) | | 0.00 | 0 |
| 99 | LC method for quantitative determination of Ciprofloxacin in… (10.22456/2527-2616.118365) | ORCID | 0.00 | 0 |
| 100 | Influence of grape seed oil on sun protection factor in suns… (10.22456/2527-2616.125327) | | 0.00 | 2 |
| 101 | Anti-Candida activity of terpenes from Salvia ovalifolia, S.… (10.22456/2527-2616.128293) | References ORCID | 0.00 | 0 |
| 102 | Quality evaluation of solid pharmaceutical preparations for… (10.22456/2527-2616.128550) | References | 0.00 | 0 |
| 103 | Stability-indicating method for the analysis of amorolfine a… (10.22456/2527-2616.128737) | References | 0.00 | 0 |
| 104 | New HPLC method for determination of fluvastatin anti-hyperl… (10.22456/2527-2616.130255) | References | 0.00 | 0 |
| 105 | Full factorial design assisted RP-UHPLC method development a… (10.22456/2527-2616.134441) | References | 0.00 | 0 |
| 106 | Microbiological evaluation of packaging obtained from cosmet… (10.22456/2527-2616.135918) | References | 0.00 | 0 |
| 107 | New knowledge for omarigliptin tablets: dissolution assay -b… (10.22456/2527-2616.136825) | References ORCID | 0.00 | 0 |
| 108 | Evaluation of the Photoprotective Potential and Antioxidant… (10.22456/2527-2616.140415) | References | 0.00 | 0 |
| 109 | A short reflection addressed to the analysts about the relat… (10.22456/2527-2616.142599) | References | 0.00 | 0 |
| 110 | Photodegradation kinetics of Bilastine in tablets (10.22456/2527-2616.142956) | References | 0.00 | 0 |
| 111 | Quantitative estimation of drugs for erectile dysfunction an… (10.22456/2527-2616.143081) | References | 0.00 | 0 |
| 112 | Systematic study of drug distribution profiles of different… (10.22456/2527-2616.143983) | References | 0.00 | 0 |
| 113 | Biotransformation on nitazoxanide by filamentous fungi - a m… (10.22456/2527-2616.145722) | | 0.00 | 0 |
| 114 | Advances in quality control through the development of a mor… (10.22456/2527-2616.146133) | | 0.00 | 0 |
| 115 | Development and validation of an HPLC-DAD analytical method… (10.22456/2527-2616.146375) | | 0.00 | 0 |
| 116 | Green method for quantification of clindamycin in capsules b… (10.22456/2527-2616.147142) | | 0.00 | 1 |
| 117 | Quality by design-assisted green uv-spectrophotometric metho… (10.22456/2527-2616.147251) | | 0.00 | 1 |
| 118 | Hydrogels containing spray-dried avobenzone and resveratrol-… (10.22456/2527-2616.147538) | | 0.00 | 0 |
| 119 | Validation of a HPLC-UV analytical and bioanalytical method… (10.22456/2527-2616.148019) | | 0.00 | 0 |
| 120 | Bioanalysis of chrysin in human plasma and analytical stabil… (10.22456/2527-2616.148193) | | 0.00 | 0 |
| 121 | Development and validation of a RP-HPLC method for simultane… (10.22456/2527-2616.148765) | | 0.00 | 0 |
| 122 | Development of Validated RP-UHPLC and Analogous UV Spectrosc… (10.22456/2527-2616.148879) | ORCID | 0.00 | 0 |
| 123 | Sibutramine identification in weight loss products marketed… (10.22456/2527-2616.149085) | | 0.00 | 0 |
| 124 | Chemical compounds from species of Croton native to South Br… (10.22456/2527-2616.149268) | | 0.00 | 0 |
| 125 | Development and validation of analytical HPLC method for qua… (10.22456/2527-2616.150106) | | 0.00 | 0 |
| 126 | Analytical Method Validation for the Detection of the Drug S… (10.22456/2527-2616.150632) | | 0.00 | 0 |
| 127 | Novel levodopa microparticles for pulmonary delivery and in… (10.22456/2527-2616.150700) | | 0.00 | 0 |
| 128 | Stability-Indicating method for determination of Tizanidine… (10.22456/2527-2616.75607) | ORCID | 0.00 | 0 |
| 129 | Development and validation of a high performance liquid chro… (10.22456/2527-2616.79216) | ORCID | 0.00 | 0 |
| 130 | Determination of Arginine and Ascorbic acid in effervescent… (10.22456/2527-2616.79222) | ORCID | 0.00 | 0 |
| 131 | Determination of water content in tea samples of Cymbopogon… (10.22456/2527-2616.79223) | ORCID | 0.00 | 0 |
| 132 | MICROBIOLOGICAL ASSAY FOR QUANTITATIVE DETERMINATION OF IMIP… (10.22456/2527-2616.87344) | ORCID | 0.00 | 0 |
| 133 | Feasibility of direct solid sampling for arsenic determinati… (10.22456/2527-2616.89766) | ORCID | 0.00 | 0 |
| 134 | Dry-Powder of Chitosan-Coated Lipid-Core Nanocapsules Contai… (10.22456/2527-2616.92750) | ORCID | 0.00 | 0 |
| 135 | template (10.22456/2527-2616.93309) | Abstract References ORCID License | 0.00 | 0 |
| 136 | Editorial Team (10.22456/2527-2616.94434) | Abstract References ORCID | 0.00 | 0 |
| 137 | Dissolution Test for Mianserin Hydrochloride in Tablets (10.22456/2527-2616.97029) | ORCID | 0.00 | 0 |